EFX
57
2
HCA
59
2
NEE
60
3
SWKS
55
4
MMC
44
-2
GILD
51
2
BDX
52
-2
MO
57
4
TGT
38
3
STI
32
-3
OKE
40
-5
ISRG
53
4
EMC
92
16
MNST
52
-3
MSI
52
2
SYK
44
-2
VRSK
19
-7
NOV
35
-4
ZTS
21
-4
AMG
66
-2
EFX
57
2
HCA
59
2
NEE
60
3
SWKS
55
4
MMC
44
-2
GILD
51
2
BDX
52
-2
MO
57
4
TGT
38
3
STI
32
-3
OKE
40
-5
ISRG
53
4
EMC
92
16
MNST
52
-3
MSI
52
2
SYK
44
-2
VRSK
19
-7
NOV
35
-4
ZTS
21
-4
AMG
66
-2
Financhill
Back

Bionano Genomics, Inc. 10K Form

Sell
1

BNGO
Bionano Genomics, Inc.

Last Price:
$1.77
Seasonality Move:
-29.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BNGO News And Ratings

See the #1 stock for the next 7 days that we like better than BNGO

BNGO Financial Statistics

Sales & Book Value

Annual Sales: $30.8M
Cash Flow: $-3.5M
Price / Cash Flow: 0
Annual Sales: $11.61
Price / Book: 0.18

Profitability

EPS (TTM): -11.39160
Net Income (TTM): $-74.3M
Gross Margin: $-10.7M
Return on Equity: -143.97%
Return on Assets: -82.99%

Bionano Genomics, Inc. Earnings Forecast

Key Bionano Genomics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 9 years for BNGO is -34.72%.
  • The Selling, General & Administrative Expenses for BNGO have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 80.59% of Revenue.
  • The Net Earning history of BNGO is -363.98% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Bionano Genomics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BNGO
CUSIP: 09075F
Website: bionano.com

Debt

Debt-to-Equity Ratio: 0.43
Current Ratio: 1.76
Quick Ratio: 1.28

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BNGO Technical Analysis vs Fundamental Analysis

Sell
1
Bionano Genomics, Inc. (BNGO) is a Sell

Is Bionano Genomics, Inc. a Buy or a Sell?